A Phase I, Single-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics in Intravenous AZD5099 After Single Ascending Doses in Healthy Male and Female Subjects.
Phase of Trial: Phase I
Latest Information Update: 30 Nov 2011
At a glance
- Drugs AZD 5099 (Primary)
- Indications Bacterial infections
- Focus Adverse reactions
- 30 Nov 2011 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 16 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 26 Apr 2011 New trial record